These mechanisms change the secretion of interleukins (ILs), tumour necrosis factor α (TNF-α), and C-reactive protein (CRP), which results in a liver inflammatory response that worsens NAFLD (19, 20). This evidence concerns the gene CRP and metabolic dysfunction-associated steatotic liver disease.